Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 12 (RPL7AP12)

Target
RPL7AP12
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L7a pseudogene 12 (RPL7AP12) is classified as a pseudogene of the ribosomal protein L7a gene family. Pseudogenes are DNA sequences that resemble functional genes but typically lack the ability to encode a functional protein due to mutations or truncations. RPL7AP12 is not known to be expressed as a protein or participate in any known biological functions and does not serve as a direct therapeutic target. It has no established role in disease and is not associated with any pharmacologic agents or considered a biomarker[10]. RPL7AP12 is *not* a protein-coding gene but a **pseudogene** arising from the functional RPL7A gene, which encodes the ribosomal protein L7a[10]. The presence of the term "pseudogene" in the canonical name and the lack of any functional protein product or known biological role means this is not a receptor, enzyme, transporter, or any other druggable or functional biological target. It is important to distinguish RPL7AP12 from its functional counterpart **RPL7A**, which is a protein component of the 60S ribosomal subunit and has some roles described in cancer biology and nuclear receptor interaction[2][5][7][8]. If your intent is to obtain information about the functional ribosomal protein L7a, refer to "Ribosomal protein L7a (RPL7A)", not its pseudogene "RPL7AP12"[7][8][10].

Other names
dJ189G13.1RPL7AL2ribosomal protein L7a like 2RPL7AP12

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 12 (RPL7AP12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 12 (RPL7AP12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call